Avid Bioservices Inc (CDMO)

[biopharm]

..PPHM will have to be very careful given we have at least 3 (and possible 4 given PACER mentioned viral clinical trials at CSM too) of our clinical trial with events that were CLEARLY in the disadvantage of PPHM and ALL in a DIFFERENT WAYS!

- 1st ln NSCLC control arm set's new SOC on itself equal to the SUPER Bavituximab results.

- Pancreatic trial sees the large and disproportional sickest patients population randomized in the Bavituximab arm (and the Bavi arm STILL has beaten the SOC but only with two weeks).

- 2nd ln NSCLC that was sabotaged with a dose switching on a registration al trial that could have set Bavituximab in commercial production rather then having to run SUNRISE. A sabotage that was EXTREMELY unfavourable for the Bavituximab arms, yet still yielded super 60% SOC improvement (conservative) and 113% SOC improvement and statistical significant in reality. And one that crossed CEO King's statement that we expected to have a commercial product in 2012.

So the next thing, if any, will be something more sophisticated and what better way then to hide it in an at first view POSITIVE event such as an EARLY STOP advice of a look-in. There is not much needed to have a hand into a IDMC. I am not saying this is going to happen, just that it could, and that PPHM needs to make sure that every move they make is on SOLID GROUND.
.....
...

CP, question....but first you had it correct regarding 1st look in stop type of sabotage

....so now, we must realize the timeline and chain of events with Pr cision For Medicine and Epiontis and something very strange here with Bird and Bird making the call for the buy, patents filed early 2013 during Sunrise trial design where blood work taken, Biomarkers etc were required and my question for all....

How could Biomarker data be utilized from Sunrise with Epiontis and PFM etc for patents and for blood tests, when the same data can't be used for Sunrise Bavi approval due to late breaking discoveries where Bavi treated patients were three ones with record breaking MOS for just the Bavi patients that were primed T cells then moved to FDA SOC ?

I think the new BODs can request this info and PR the results